These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9669958)

  • 1. Teaching the brain to take drugs.
    Wickelgren I
    Science; 1998 Jun; 280(5372):2045-6. PubMed ID: 9669958
    [No Abstract]   [Full Text] [Related]  

  • 2. Potential neuroprotective effects of acamprosate.
    Koob GF; Mason BJ; De Witte P; Littleton J; Siggins GR
    Alcohol Clin Exp Res; 2002 Apr; 26(4):586-92. PubMed ID: 11981137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic approaches to the management of alcoholism.
    Anton RF
    J Clin Psychiatry; 2001; 62 Suppl 20():11-7. PubMed ID: 11584870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of acamprosate on alcohol-cue reactivity and alcohol priming in dependent patients: a randomized controlled trial.
    Hammarberg A; Jayaram-Lindström N; Beck O; Franck J; Reid MS
    Psychopharmacology (Berl); 2009 Jul; 205(1):53-62. PubMed ID: 19319508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychiatric drugs. Excited by glutamate.
    Holden C
    Science; 2003 Jun; 300(5627):1866-8. PubMed ID: 12817119
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of alcohol-dependent outpatients with acamprosate: a clinical review.
    Mason BJ
    J Clin Psychiatry; 2001; 62 Suppl 20():42-8. PubMed ID: 11584875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medications for alcohol, illicit drug, and tobacco dependence. An update of research findings.
    Litten RZ; Allen JP
    J Subst Abuse Treat; 1999 Mar; 16(2):105-12. PubMed ID: 10023607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NEUROBIOLOGICAL BASES OF ALCOHOL ADDICTION.
    Matošić A; Marušić S; Vidrih B; Kovak-Mufić A; Cicin-Šain L
    Acta Clin Croat; 2016 Mar; 55(1):134-50. PubMed ID: 27333729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acamprosate during and after acute alcohol withdrawal: a double-blind placebo-controlled study in Spain.
    Gual A; Lehert P
    Alcohol Alcohol; 2001; 36(5):413-8. PubMed ID: 11524307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind, placebo-controlled pilot trial of acamprosate for the treatment of cocaine dependence.
    Kampman KM; Dackis C; Pettinati HM; Lynch KG; Sparkman T; O'Brien CP
    Addict Behav; 2011 Mar; 36(3):217-21. PubMed ID: 21112155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acamprosate: an alcoholism treatment that may not be what we thought.
    Heilig M
    Neuropsychopharmacology; 2014 Mar; 39(4):781-2. PubMed ID: 24518272
    [No Abstract]   [Full Text] [Related]  

  • 12. Naltrexone versus acamprosate: one year follow-up of alcohol dependence treatment.
    Rubio G; Jiménez-Arriero MA; Ponce G; Palomo T
    Alcohol Alcohol; 2001; 36(5):419-25. PubMed ID: 11524308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acamprosate.
    Drugs R D; 2002; 3(1):13-8. PubMed ID: 11881522
    [No Abstract]   [Full Text] [Related]  

  • 14. Acamprosate for alcohol dependence?
    Drug Ther Bull; 1997 Sep; 35(9):70-2. PubMed ID: 9350085
    [No Abstract]   [Full Text] [Related]  

  • 15. Does the alcoholic's remedy come in a pill?
    Gordon SM
    Behav Healthc Tomorrow; 2001 Aug; 10(4):SR29-30, SR34. PubMed ID: 11496583
    [No Abstract]   [Full Text] [Related]  

  • 16. [Acamprosate--a novel treatment for alcoholism].
    Golovko SI; Zefirov SIu; Golovko AI; Shpilenia LS; Nekrasov IuA
    Eksp Klin Farmakol; 2000; 63(3):70-3. PubMed ID: 10934602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?
    Richardson K; Baillie A; Reid S; Morley K; Teesson M; Sannibale C; Weltman M; Haber P
    Addiction; 2008 Jun; 103(6):953-9. PubMed ID: 18482418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacological treatment of alcohol dependence. Acamprosate and naltrexone offer new approach].
    Berglund M; Balldin J; Bendtsen P; Borg S; Franck J; Gustafsson L; Halldin J; Månsson M; Nilsson LH; Stolt G; Willander A
    Lakartidningen; 1997 Jul; 94(30-31):2645-8. PubMed ID: 9273426
    [No Abstract]   [Full Text] [Related]  

  • 19. Acamprosate decreases the hypermotility during repeated ethanol withdrawal.
    Dahchour A; De Witte P
    Alcohol; 1999 May; 18(1):77-81. PubMed ID: 10386669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neurobiology, clinical efficacy and safety of acamprosate in the treatment of alcohol dependence.
    Mason BJ; Heyser CJ
    Expert Opin Drug Saf; 2010 Jan; 9(1):177-88. PubMed ID: 20021295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.